| Taylor John Abel, MD | |
|
4401 Penn Ave, Pittsburgh, PA 15224-1334 | |
| (412) 692-8142 | |
| Not Available |
| Full Name | Taylor John Abel |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 14 Years |
| Location | 4401 Penn Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558681163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | PENDING (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.
A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).
Biomarkers could revolutionise the early detection of and therapy for Alzheimer's disease. However, experts attending the Congress of the European Academy of Neurology in Copenhagen criticized that the big breakthroughs are slow in coming because of a lack of priorities in research.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.
› Verified 8 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.
A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).
Biomarkers could revolutionise the early detection of and therapy for Alzheimer's disease. However, experts attending the Congress of the European Academy of Neurology in Copenhagen criticized that the big breakthroughs are slow in coming because of a lack of priorities in research.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.
› Verified 8 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.
A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).
Biomarkers could revolutionise the early detection of and therapy for Alzheimer's disease. However, experts attending the Congress of the European Academy of Neurology in Copenhagen criticized that the big breakthroughs are slow in coming because of a lack of priorities in research.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Taylor John Abel, MD 4401 Penn Ave, Pittsburgh, PA 15224-1334 Ph: () - | Taylor John Abel, MD 4401 Penn Ave, Pittsburgh, PA 15224-1334 Ph: (412) 692-8142 |
News Archive
Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.
A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).
Biomarkers could revolutionise the early detection of and therapy for Alzheimer's disease. However, experts attending the Congress of the European Academy of Neurology in Copenhagen criticized that the big breakthroughs are slow in coming because of a lack of priorities in research.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.
› Verified 8 days ago
Pascal Olivier Zinn, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5150 Centre Ave Ste 433, Pittsburgh, PA 15232 Phone: 412-647-7614 Fax: 412-623-4653 | |
Enyinna L Nwachuku, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St, Suite B-400, Pittsburgh, PA 15213 Phone: 412-647-6777 Fax: 412-647-6483 | |
David Zorub, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5200 Centre Ave, Suite 617, Pittsburgh, PA 15232 Phone: 412-623-2972 | |
David Kaufmann, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St, Suite 300, Pittsburgh, PA 15219 Phone: 412-471-4772 | |
Sean Polster, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Lothrop St Ste 521, Suite B400, Pittsburgh, PA 15213 Phone: 412-647-8186 | |
Dr. Ali Fadhil, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St Ste 311, Pittsburgh, PA 15219 Phone: 412-647-2304 | |
Daryl Pinion Fields Ii, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St Ste B-400, Pittsburgh, PA 15213 Phone: 320-224-2705 |